Blog
Is Microsoft Stock a Buy Now?
Microsoft (NASDAQ: MSFT) stock surged higher after reporting earnings for its fiscal third quarter on Tuesday. The software giant has not escaped the effects of the sell-off that has hit its
Should Investors Be Worried About Tech Stock Valuations?
For years, hearing news outlets call tech stocks "overvalued" has been normal. But when was the last time you heard someone argue that they were actually undervalued? While many people agree with
2 Monster Warren Buffett Stock-Split Stocks to Buy Right Now
As one of history's most successful moneymen, investors look to Warren Buffett for guidance when it comes to stock picking and finances. Lately, investors have also been loving stock splits.
3 Great Energy Stocks You Can Buy for Under $100
Investors often think that you need a lot of money to get started, but that's just not true anymore -- especially since many brokers will allow you to make free trades. So even if your budget is
These Charts Explain Why I'm Holding This Healthcare Company
The number of organ transplants has continued to grow over the years. Unfortunately, it seems as though supply is not going to catch up to demand any time soon.
With such a backlog of transplants
Counting on the Maximum Social Security Benefit? You May Want to Reconsider
For many people, Social Security will play a sizable role in their retirement income. For decades, Americans pay Social Security taxes, planning on receiving monthly payouts in retirement that will
Amazon vs. Shopify Stock: Better Buy Now?
Shopify (NYSE: SHOP) has a solid brand, a great position in the market, and the stock is at an over 50% discount right now. In this Motley Fool Live segment from "Ask Us Anything," recorded on April
Despite Low Margins, These 2 Dividend Stocks Are Cash Machines
Earnings season is underway and it has only added to the broader stock market's volatility over the past several months. Major moves to the upside and downside seem like the norm nowadays for many
Should You Sell AMD Stock This Earnings Season?
With shares down 41% so far in 2022, Advanced Micro Devices (NASDAQ: AMD) investors will be hoping for a turnaround in the stock's fortunes when the company releases its first-quarter results on May
Is DexCom Stock a Buy Now?
If you were to strictly look at earnings multiples, you could easily miss a top growth stock like DexCom (NASDAQ: DXCM). Initially, value investors might scoff at the whopping 200+ times earnings
Could Recent Wage Disputes Impact Stocks?
Recently, wage pressure has made headlines in cities all around the country. In this video clip from "Ask Us Anything" on Motley Fool Live, recorded on April 22, Fool.com contributor Matt Frankel
3 Major Investing Mistakes to Avoid During a Down Market
It's no secret that 2022 has been a tough year from a stock market perspective. Stocks have spent many days over the past four months dipping into correction territory. And a lot of investors have
Buy This World-Leading Fintech While It's Down 70%
Technology stocks have suffered a great deal in recent times. With inflation reaching 40-year highs, expected interest rate hikes, and global fear surrounding Russia and Ukraine, investor sentiment
Can Blockbuster Films Carry the Load for AMC in 2022?
AMC Entertainment Group (NYSE: AMC) is scheduled to report fiscal 2022 first-quarter earnings on May 4. The movie theater chain is bouncing back after the coronavirus pandemic forced it to shut its
Could This Eliminate Shiba Inu's Biggest Problem?
Shiba Inu (CRYPTO: SHIB) and its investors won big last year after the popular meme token soared a jaw-dropping 45,000,000%. Support from Shiba Inu's community -- the Shib Army -- helped power the
How to Invest in Real Estate During a Mega Inflation Period
As a general rule, real estate investments -- such as rental properties or stock-based investments like real estate investment trusts (REITs) -- tend to hold up well in inflationary environments
3 Things About BioNTech That Smart Investors Know
For most investors, the story of BioNTech (NASDAQ: BNTX) will always start with the pandemic and its partnership with Pfizer (NYSE: PFE) to deliver Comirnaty, the messenger RNA (mRNA) vaccine for
Buy or Sell a Stock if the Company Doesn't Provide Guidance?
With rising interest rates, the war in Ukraine, and several other factors influencing the markets right now, it can be a difficult time for companies to issue guidance. In this Motley Fool Live
1 Warren Buffett Growth Stock Down 90% to Buy Right Now
Warren Buffett stands as one of history's most successful investors, and he's dispensed plenty of quotable wisdom in his decades of guiding Berkshire Hathaway to incredible returns. Perhaps his
Will I Owe Taxes If I Convert My 401(k) to a Roth IRA in 2022?
Moving money from an old 401(k) to a Roth IRA (individual retirement account) can set you up for tax-free withdrawals later in life. But before you do so, you should iron out the details of your
3 Trustworthy CEOs With Different Perspectives on Inflation
Inflation is everywhere. It's in our lives and in the news. Americans have become fixated on it. So has the financial media. And the companies that report earnings are now starting to outline just
Should You Invest in Stablecoins?
A stablecoin Is a cryptocurrency designed to match the value of an ordinary currency such as the U.S. dollar or the euro. There are many stablecoins on the market today, and the largest ones are the
2 Amazing Numbers From Roku's Earnings Report
If Roku (NASDAQ: ROKU) investors were looking for some reprieve from the stock's brutal beating over the past year, they finally got it on Thursday. Not only did the stock rise more than 8% during
Frontier Group Holdings, Inc. (ULCC) Q1 2022 Earnings Call Transcript
Image source: The Motley Fool.
Frontier Group Holdings, Inc. (NASDAQ: ULCC)Q1 2022 Earnings CallApr 28, 2022, 4:30 p.m. ET
Operator
Source Fool.com
Could This 1 Detail Could Keep Intuitive Surgical Ahead of Rivals?
Intuitive Surgical (NASDAQ: ISRG) is the leader in robotic surgery -- and by quite a bit. The company holds 79% of the global market, according to BIS Research data. And its closest rival -- Stryker


